Pomdoctor Limited Regains Nasdaq Compliance Following Minimum Bid Price Requirement
Pomdoctor Limited (POM) has officially regained compliance with the Nasdaq's minimum bid price requirement. This development follows a period of regulatory scrutiny regarding the company's stock valuation relative to exchange standards. As a direct consequence of regaining compliance, the scheduled hearing before the Nasdaq Hearings Panel, which was originally set for November 12, 2026, has been cancelled. The company confirmed that its standing on the exchange is now secure.